Avantor, Inc. Current Income Tax Expense (Benefit)
Avantor, Inc. (AVTR) reported Current Income Tax Expense (Benefit) of $81.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-11
- Avantor, Inc. current income tax expense (benefit) for fiscal 2025 was $81.20M, a 57.11% decline from fiscal 2024.
- Avantor, Inc. current income tax expense (benefit) for fiscal 2024 was $189.30M, a 27.69% decline from fiscal 2023.
- Avantor, Inc. current income tax expense (benefit) for fiscal 2023 was $261.80M, a 12.02% increase from fiscal 2022.
- Avantor, Inc. current income tax expense (benefit) for fiscal 2022 was $233.70M, a 17.97% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $81.20M 10-K · filed 2026-02-11 |
| 2024-12-31 | $189.30M 10-K · filed 2026-02-11 |
| 2023-12-31 | $261.80M 10-K · filed 2026-02-11 |
| 2022-12-31 | $233.70M 10-K · filed 2025-02-07 |
| 2021-12-31 | $198.10M 10-K · filed 2024-02-14 |
| 2020-12-31 | $33.20M 10-K · filed 2023-02-14 |
| 2019-12-31 | $109.50M 10-K · filed 2022-02-11 |
| 2018-12-31 | $77.00M 10-K · filed 2021-02-16 |
| 2017-12-31 | $115.70M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |